+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Laron Syndrome (LS) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Laron Syndrome (LS) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Limb Girdle Muscular Dystrophy (LGMD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Limb Girdle Muscular Dystrophy (LGMD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Malignant Pleural Effusion - Epidemiology Forecast to 2032 - Product Thumbnail Image

Malignant Pleural Effusion - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Moderate To Severe Acute Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Moderate To Severe Acute Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Darbepoetin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Darbepoetin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Epoetin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Epoetin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Teriparatide- Biosimilar Insight, 2022 - Product Thumbnail Image

Teriparatide- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Autoimmune pulmonary alveolar proteinosis (aPAP) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Autoimmune pulmonary alveolar proteinosis (aPAP) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Netherton Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Netherton Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis (NCFB) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Non-Cystic Fibrosis Bronchiectasis (NCFB) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cytomegalovirus (CMV) Infection - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Cytomegalovirus (CMV) Infection - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Urinary Incontinence - Epidemiology Forecast to 2032 - Product Thumbnail Image

Urinary Incontinence - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cushing's Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cushing's Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Diabetic Retinopathy - Epidemiology Forecast to 2032 - Product Thumbnail Image

Diabetic Retinopathy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Refractory Angina - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Refractory Angina - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Adult-onset Still's Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Adult-onset Still's Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Progressive Supranuclear Palsy - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Progressive Supranuclear Palsy - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Multiple System Atrophy (MSA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Multiple System Atrophy (MSA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Geographic Atrophy (GA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Geographic Atrophy (GA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more